Cancer Research UK has announced its largest-ever transatlantic collaborations as part of the second round of its Grand Challenge initiative, in which the charity is seeking to fund “research without borders”.
The charity announced on 23 January that it would fund three five-year research projects with around £20 million each, focusing on manipulating the microbiome to fight bowel cancer, cancers associated with chronic inflammation and why some cancers are specific to certain tissues.
All three projects will be led by researchers at US institutions, of which five are based in Boston—Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, the Brigham and Women’s Hospital, and the Dana-Farber Cancer Institute—and sixth is the University of California in San Francisco. A spokesman for Cancer Research UK said this was the first time the charity had worked on this scale with the US, as the funder looks to “fund research without borders”.